Annual Shareholders Equity
$153.15 M
+$20.08 M+15.09%
December 31, 2024
Summary
- As of March 3, 2025, PRME annual stockholders equity is $153.15 million, with the most recent change of +$20.08 million (+15.09%) on December 31, 2024.
- During the last 3 years, PRME annual shareholders equity has fallen by -$86.41 million (-36.07%).
- PRME annual shareholders equity is now -51.58% below its all-time high of $316.27 million, reached on December 31, 2022.
Performance
PRME Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$153.15 M
-$36.35 M-19.18%
December 31, 2024
Summary
- As of March 3, 2025, PRME quarterly stockholders equity is $153.15 million, with the most recent change of -$36.35 million (-19.18%) on December 31, 2024.
- Over the past year, PRME quarterly shareholders equity has dropped by -$90.62 million (-37.17%).
- PRME quarterly shareholders equity is now -37.17% below its all-time high of $243.77 million, reached on March 31, 2024.
Performance
PRME Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PRME Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.1% | -37.2% |
| 3 y3 years | -36.1% | -37.2% |
| 5 y5 years | +357.5% | -37.2% |
PRME Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.6% | +15.1% | -37.2% | +15.1% |
| 5 y | 5-year | -51.6% | +357.5% | -37.2% | +15.1% |
| alltime | all time | -51.6% | +357.5% | -37.2% | +15.1% |
Prime Medicine Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $153.15 M(+15.1%) | $153.15 M(-19.2%) |
| Sep 2024 | - | $189.50 M(-3.6%) |
| Jun 2024 | - | $196.59 M(-19.4%) |
| Mar 2024 | - | $243.77 M(+83.2%) |
| Dec 2023 | $133.07 M(-57.9%) | $133.07 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $316.27 M(+32.0%) | - |
| Sep 2022 | - | $172.70 M(-14.0%) |
| Jun 2022 | - | $200.74 M(-16.2%) |
| Dec 2021 | $239.56 M(+615.7%) | $239.56 M |
| Dec 2020 | $33.47 M | - |
FAQ
- What is Prime Medicine annual stockholders equity?
- What is the all time high annual shareholders equity for Prime Medicine?
- What is Prime Medicine annual shareholders equity year-on-year change?
- What is Prime Medicine quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Prime Medicine?
- What is Prime Medicine quarterly shareholders equity year-on-year change?
What is Prime Medicine annual stockholders equity?
The current annual shareholders equity of PRME is $153.15 M
What is the all time high annual shareholders equity for Prime Medicine?
Prime Medicine all-time high annual stockholders equity is $316.27 M
What is Prime Medicine annual shareholders equity year-on-year change?
Over the past year, PRME annual stockholders equity has changed by +$20.08 M (+15.09%)
What is Prime Medicine quarterly stockholders equity?
The current quarterly shareholders equity of PRME is $153.15 M
What is the all time high quarterly shareholders equity for Prime Medicine?
Prime Medicine all-time high quarterly stockholders equity is $243.77 M
What is Prime Medicine quarterly shareholders equity year-on-year change?
Over the past year, PRME quarterly stockholders equity has changed by -$90.62 M (-37.17%)